Lymphoma

A national survey demonstrated shared feelings across all blood cancer types about treatment options and their side effects, as well as other social, financial and emotional aspects.

The majority of adolescent and young adult (AYA) patients who are diagnosed with cancer are expected to live past the five-year mark, though survival and health outcomes seem to differ by disease type, according to recent research published in the journal Cancer.

A look at how one cancer survivor has witnessed life-changing medical advancements over the years.

Four ways of helping cancer survivors deal with anxiety and depression.

There can be definite struggles for childhood cancer survivors, even many years later.

CURE spoke with the chief medical officer of the Leukemia & Lymphoma Society to hear what she thinks are important next steps in improving patient outcomes.

A new expert guideline for managing immunotherapy’s side effects has been released.

The FDA has granted an accelerated approval to Keytruda (pembrolizumab) for the treatment of adult and pediatric patients with refractory primary mediastinal large B-cell lymphoma (PMBCL), or those who have relapsed after 2 or more prior lines of therapy.

Nearly 20 percent of hematopoietic stem cell transplant (HSCT) survivors reported using cannabis, not just to ease physical and emotional side effects, but in the hopes that it would help treat their cancer, according to patient survey results presented at the 2018 of American Society of Clinical Oncology (ASCO) Annual Meeting.

How I escaped from cancer as a kid.

The Food and Drug Administration (FDA) approved Venclexta (venetoclax) in combination with Rituxan (rituximab) for the treatment of patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), with or without the genetic mutation 17p deletion, who have received at least one prior therapy.

How not being a writer and still writing helped me through cancer and cancer treatment.

How skateboarding helped get me through cancer treatment at age 11.

How two crazy uncles have helped me through my battles with cancer, and eventually faced battles of their own.

How even "Indiana Jones" can remind a survivor of medical procedures from years ago.

The Leukemia & Lymphoma Society's (LLS) Clinical Trial Support Center helps patients with blood cancers find clinical trials that are right for them.

How a break from the hospital led directly to an encounter with the police.

The story of the "Hear the Heart" Tour.

How a young boy on chemo marked the days until the end of his treatments.

How a clown named Miss Sydney helped so many kids battling cancer.

The Food and Drug Administration (FDA) approved Kymriah (tisagenlecleucel) – a CAR-T cell therapy – for the treatment of adult patients who have relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who have relapsed or are ineligible for an autologous stem cell transplant (ASCT).

Perspective is important with cancer and remission.

This cancer survivor shares his experience with advancements in cancer treatment.

Thinking back on my friends who fought cancer with me can sometimes be daunting, but I like to look for the silver lining.

Tavalisse (fostamatinib) was granted approval by the Food and Drug Administration (FDA) for patients with chronic immune thrombocytopenia (ITP) after they had an insufficiencent response to another therapy.

Connections on the cancer ward are Inevitable, but fear of loss can make those relationships painful.

Tests like these are growing increasingly important, as TOO results lead to treatment changes about 65 percent of the time and a site treatment change about 35 percent of the time, according to Cancer Genetics.

When I was a kid, my Walkman helped me through my chemotherapy treatments.

The Food and Drug Administration (FDA) granted duvelisib a priority review to a new drug application (NDA) for full approval to treat patients who have relapsed or refractory chronic lymphocytic leukemia or small lymphocytic leukemia (CLL/SLL). The FDA also granted an accelerated approval for the treatment of patients with relapsed or refractory follicular lymphoma.